What is the address of WESTENBOHM MEDICAL?

The registered office of WESTENBOHM MEDICAL is located at Wehdriggasse,Rodt 14, 4780 Sankt Vith.

Is WESTENBOHM MEDICAL still active?

Yes. According to the CBE (31 October 2026) WESTENBOHM MEDICAL is active, legal situation “Normale toestand”, started on 15 May 2009.

Is WESTENBOHM MEDICAL registered on Peppol?

No, WESTENBOHM MEDICAL is currently not registered on the Peppol network.

What is the enterprise number of WESTENBOHM MEDICAL?

The enterprise number of WESTENBOHM MEDICAL is BE0811835857.

When was WESTENBOHM MEDICAL founded?

WESTENBOHM MEDICAL was founded on 15 May 2009.

Who are the directors of WESTENBOHM MEDICAL?

According to the 2025 annual accounts, the directors of WESTENBOHM MEDICAL are: PAUL-ANDRE WESTENBOHM.

Is WESTENBOHM MEDICAL a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 15 May 2009; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did WESTENBOHM MEDICAL make in 2025?

WESTENBOHM MEDICAL posted a profit after taxes of € 354,454 in financial year 2025.

What is the revenue of WESTENBOHM MEDICAL?

As a small company, WESTENBOHM MEDICAL is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 537,585.

WESTENBOHM MEDICAL (Private Limited) - Sankt Vith

Dossier WESTENBOHM MEDICAL, printed on 31 October 2026 from databakkes.be/en/0811835857/westenbohm-medical. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

WESTENBOHM MEDICAL from Sankt Vith, company number BE0811835857, closed financial year 2025 with a result of € 354,454 after tax. For that financial year WESTENBOHM MEDICAL recorded a gross margin of € 537,585 and equity of € 1.1 million. Compared with financial year 2024, the result moved from € 322,355 to € 354,454. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 29, 2026.

What it is worth Growing

€ 1.1 million

▲ 51% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 354,454

▲ 10% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 1 million

▲ 54% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 1 million.

People and assets in 2025

Vehicles and equipment

€ 40,181

▼ 29% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 3,046

▼ 28% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 35,416

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 235,572 Gross margin 2022: € 235,572 First fiscal year in the series	€ 320,760 Gross margin 2023: € 320,760 ▲ 36% vs 2022 (€ 235,572) Favourable step	€ 497,967 Gross margin 2024: € 497,967 ▲ 55% vs 2023 (€ 320,760) Favourable step	€ 537,585 Gross margin 2025: € 537,585 ▲ 8% vs 2024 (€ 497,967) Favourable step	▲ 8%
Profit after taxes	€ 148,798 Profit after taxes 2022: € 148,798 First fiscal year in the series	€ 205,005 Profit after taxes 2023: € 205,005 ▲ 38% vs 2022 (€ 148,798) Favourable step	€ 322,355 Profit after taxes 2024: € 322,355 ▲ 57% vs 2023 (€ 205,005) Favourable step	€ 354,454 Profit after taxes 2025: € 354,454 ▲ 10% vs 2024 (€ 322,355) Favourable step	▲ 10%
Equity	€ 424,808 Equity 2022: € 424,808 First fiscal year in the series	€ 379,398 Equity 2023: € 379,398 ▼ 11% vs 2022 (€ 424,808) Unfavourable step	€ 701,753 Equity 2024: € 701,753 ▲ 85% vs 2023 (€ 379,398) Favourable step	€ 1,056,207 Equity 2025: € 1,056,207 ▲ 51% vs 2024 (€ 701,753) Favourable step	▲ 51%
Total debts	€ 33,743 Total debts 2022: € 33,743 First fiscal year in the series	€ 23,342 Total debts 2023: € 23,342 ▼ 31% vs 2022 (€ 33,743) Favourable step	€ 44,207 Total debts 2024: € 44,207 ▲ 89% vs 2023 (€ 23,342) Unfavourable step	€ 38,467 Total debts 2025: € 38,467 ▼ 13% vs 2024 (€ 44,207) Favourable step	▼ 13%
Cash	€ 400,961 Cash 2022: € 400,961 First fiscal year in the series	€ 303,550 Cash 2023: € 303,550 ▼ 24% vs 2022 (€ 400,961) Unfavourable step	€ 677,080 Cash 2024: € 677,080 ▲ 123% vs 2023 (€ 303,550) Favourable step	€ 1,042,006 Cash 2025: € 1,042,006 ▲ 54% vs 2024 (€ 677,080) Favourable step	▲ 54%
Land & buildings	€ 18,058 Land & buildings 2022: € 18,058 First fiscal year in the series	€ 6,872 Land & buildings 2023: € 6,872 ▼ 62% vs 2022 (€ 18,058) Unchanged	-	-
Retained profit	€ 412,408 Retained profit 2022: € 412,408 First fiscal year in the series	€ 366,998 Retained profit 2023: € 366,998 ▼ 11% vs 2022 (€ 412,408) Unfavourable step	€ 689,353 Retained profit 2024: € 689,353 ▲ 88% vs 2023 (€ 366,998) Favourable step	€ 1,043,807 Retained profit 2025: € 1,043,807 ▲ 51% vs 2024 (€ 689,353) Favourable step	▲ 51%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 250,414 Dividend 2023: € 250,414 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 250,414) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 18,534 Bank debt 2022: € 18,534 First fiscal year in the series	€ 7,547 Bank debt 2023: € 7,547 ▼ 59% vs 2022 (€ 18,534) Favourable step	€ 1,914 Bank debt 2024: € 1,914 ▼ 75% vs 2023 (€ 7,547) Favourable step	€ 0 Bank debt 2025: € 0 ▼ 100% vs 2024 (€ 1,914) Favourable step	▼ 100%
Balance sheet total	€ 458,550 Balance sheet total 2022: € 458,550 First fiscal year in the series	€ 402,740 Balance sheet total 2023: € 402,740 ▼ 12% vs 2022 (€ 458,550) Unchanged	€ 745,960 Balance sheet total 2024: € 745,960 ▲ 85% vs 2023 (€ 402,740) Unchanged	€ 1,094,674 Balance sheet total 2025: € 1,094,674 ▲ 47% vs 2024 (€ 745,960) Unchanged	▲ 47%

Key figures of WESTENBOHM MEDICAL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to WESTENBOHM MEDICAL?

What happened at WESTENBOHM MEDICAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 29, 2026 New annual accounts for financial year 2025: profit of € 354,454 (▲ 10% vs 2024). filed late Source: NBB ↗
May 15, 2009 Start of the company according to the CBE. KBO

In short

From € 148,798 profit in 2022 to € 354,454 profit in 2025.

Paid € 461,847 in corporate taxes since 2022.

Best year ever: 2025, with € 354,454 profit.

Paid out € 250,414 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

PAUL-ANDRE WESTENBOHM

WESTENBOHM MEDICAL

Behind WESTENBOHM MEDICAL is PAUL-ANDRE WESTENBOHM.

Directors

According to the 2025 annual accounts

PAUL-ANDRE WESTENBOHM

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Wehdriggasse,Rodt 14

4780 Sankt Vith

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0811.835.857
VAT number: BE 0811.835.857
Registered office: Wehdriggasse,Rodt 14, 4780 Sankt Vith
Names & denominations: WESTENBOHM MEDICAL
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 15 May 2009
Peppol: Not registered
Contact: +3280228227

View on CBE Public ↗ Annual accounts (NBB) ↗